대한치매학회지 (Dementia and Neurocognitive Disorders)

대한치매학회 (Korean Dementia Association)
권호 표지
DOI QR코드

DOI QR Code

Diagnostic Tools for Alzheimer's Disease: A Narrative Review Based on Our Own Research Experience

  • So-Hee Park (Department of Neurology, Bobath Memorial Hospital) ;
  • Kyoung Ja Kwon (Center for Geriatric Neuroscience Research, Institute of Biomedical Science and Technology, Konkuk University School of Medicine) ;
  • Min Young Kim (Department of Neurology, Konkuk University School of Medicine) ;
  • Jae-Hun Kim (Department of Radiology, Samsung Medical Center, Sungkyunkwan University School of Medicine) ;
  • Won-Jin Moon (Department of Radiology, Konkuk University School of Medicine) ;
  • Hui Jin Ryu (Department of Neurology, Konkuk University School of Medicine) ;
  • Jae Won Jang (Department of Neurology, Kangwon National University Hospital, Kangwon National University) ;
  • Yeonsil Moon (Department of Neurology, Konkuk University School of Medicine) ;
  • K-ARPI (K-ARPI)
  • 투고 : 2023.01.31
  • 심사 : 2023.02.07
  • 발행 : 2023.01.31
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Alzheimer's disease (AD), one of the most representative neurodegenerative diseases, has diverse neurobiological and pathophysiological mechanisms. Treatment strategies targeting a single mechanism have repeated faced failures because the mechanism of neuronal cell death is very complex that is not fully understood yet. Since complex mechanisms exist to explain AD, a variety of diagnostic biomarkers for diagnosing AD are required. Moreover, standardized evaluations for comprehensive diagnosis using neuropsychological, imaging, and laboratory tools are needed. In this review, we summarize the latest clinical, neuropsychological, imaging, and laboratory evaluations to diagnose patients with AD based on our own experience in conducting a prospective study.

키워드

과제정보

The Korean AD Research Platform Initiative based on Immune-inflammatory biomarkers (K-ARPI) Investigators are as follows: Seung Hyun Kim and Hee-Jin Kim (Hanyang University Hospital), Yeonsil Moon (Konkuk University Hospital), Jae Sung Bae and Hee Kyung Jin (Kyungpook National University), Beoung-Chae Kim (Chonnam National University Medical School), Ho Jin Choi (Hanyang University College of Medicine), Chan-Nyoung Lee (Korea University Hospital), Youngsoon Yang (Seoul Veterans Hospital), Yunjeong Hong (Uijeongbu St. Mary's Hospital), Jae-Won Jang (Kangwon National University Hospital), So-Hee Park (Bobath Memorial Hospital), and Kyoung Ja Kwon (Konkuk University School of Medicine).

참고문헌

  1. Kim SH, Noh MY, Kim HJ, Oh KW, Park J, Lee S, et al. A therapeutic strategy for Alzheimer's disease focused on immune-inflammatory modulation. Dement Neurocogn Disord 2019;18:33-46. https://doi.org/10.12779/dnd.2019.18.2.33
  2. Jack CR Jr, Bennett DA, Blennow K, Carrillo MC, Dunn B, Haeberlein SB, et al. NIA-AA research framework: toward a biological definition of Alzheimer's disease. Alzheimers Dement 2018;14:535-562. https://doi.org/10.1016/j.jalz.2018.02.018
  3. Dubois B, Villain N, Frisoni GB, Rabinovici GD, Sabbagh M, Cappa S, et al. Clinical diagnosis of Alzheimer's disease: recommendations of the International Working Group. Lancet Neurol 2021;20:484-496. https://doi.org/10.1016/S1474-4422(21)00066-1
  4. Jahng S, Na DL, Kang Y. Constructing a composite score for the Seoul Neuropsychological Screening Battery-Core. Dement Neurocogn Disord 2015;14:137-142. https://doi.org/10.12779/dnd.2015.14.4.137
  5. Pasquier F, Leys D, Weerts JG, Mounier-Vehier F, Barkhof F, Scheltens P. Inter- and intraobserver reproducibility of cerebral atrophy assessment on MRI scans with hemispheric infarcts. Eur Neurol 1996;36:268-272. https://doi.org/10.1159/000117270
  6. Scheltens P, Leys D, Barkhof F, Huglo D, Weinstein HC, Vermersch P, et al. Atrophy of medial temporal lobes on MRI in "probable" Alzheimer's disease and normal ageing: diagnostic value and neuropsychological correlates. J Neurol Neurosurg Psychiatry 1992;55:967-972. https://doi.org/10.1136/jnnp.55.10.967
  7. Enkirch SJ, Traschutz A, Muller A, Widmann CN, Gielen GH, Heneka MT, et al. The ERICA score: an MR imaging-based visual scoring system for the assessment of entorhinal cortex atrophy in Alzheimer disease. Radiology 2018;288:226-333. https://doi.org/10.1148/radiol.2018171888
  8. Wattjes MP, Henneman WJ, van der Flier WM, de Vries O, Traber F, Geurts JJ, et al. Diagnostic imaging of patients in a memory clinic: comparison of MR imaging and 64-detector row CT. Radiology 2009;253:174-183. https://doi.org/10.1148/radiol.2531082262
  9. Cavallin L, Loken K, Engedal K, Oksengard AR, Wahlund LO, Bronge L, et al. Overtime reliability of medial temporal lobe atrophy rating in a clinical setting. Acta Radiol 2012;53:318-323. https://doi.org/10.1258/ar.2012.110552
  10. Claus JJ, Staekenborg SS, Holl DC, Roorda JJ, Schuur J, Koster P, et al. Practical use of visual medial temporal lobe atrophy cut-off scores in Alzheimer's disease: validation in a large memory clinic population. Eur Radiol 2017;27:3147-3155. https://doi.org/10.1007/s00330-016-4726-3
  11. Moon WJ. Alzheimer dementia and microvascular pathology: blood-brain barrier permeability imaging. J Korean Soc Radiol 2020;81:488-500. https://doi.org/10.3348/jksr.2020.81.3.488
  12. Park M, Moon WJ, Structural MR. Structural MR imaging in the diagnosis of Alzheimer's disease and other neurodegenerative dementia: current imaging approach and future perspectives. Korean J Radiol 2016;17:827-845. https://doi.org/10.3348/kjr.2016.17.6.827
  13. Fazekas F, Chawluk JB, Alavi A, Hurtig HI, Zimmerman RA. MR signal abnormalities at 1.5 T in Alzheimer's dementia and normal aging. AJR Am J Roentgenol 1987;149:351-356. https://doi.org/10.2214/ajr.149.2.351
  14. Moon Y, Moon WJ, Kim H, Han SH. Regional atrophy of the insular cortex is associated with neuropsychiatric symptoms in Alzheimer's disease patients. Eur Neurol 2014;71:223-229. https://doi.org/10.1159/000356343
  15. Thrippleton MJ, Backes WH, Sourbron S, Ingrisch M, van Osch MJ, Dichgans M, et al. Quantifying blood-brain barrier leakage in small vessel disease: review and consensus recommendations. Alzheimers Dement 2019;15:840-858. https://doi.org/10.1016/j.jalz.2019.01.013
  16. Lee JY, Park JE, Chung MS, Oh SW, Moon WJ. Expert opinions and recommendations for the clinical use of quantitative analysis software for MRI-based brain volumetry. J Korean Soc Radiol 2021;82:1124-1139. https://doi.org/10.3348/jksr.2020.0174
  17. Jeong SY, Suh CH, Park HY, Heo H, Shim WH, Kim SJ. Brain MRI-based artificial intelligence software in patients with neurodegenerative diseases: current status. J Korean Soc Radiol 2022;83:473-485. https://doi.org/10.3348/jksr.2022.0048
  18. Moon Y. A Guide for Researchers in Precision Medicine Based on Immune Modulation in Alzheimer's Disease. Seoul: Median Book, 2023.
  19. Farber SA, Nitsch RM, Schulz JG, Wurtman RJ. Regulated secretion of beta-amyloid precursor protein in rat brain. J Neurosci 1995;15:7442-7451. https://doi.org/10.1523/JNEUROSCI.15-11-07442.1995
  20. Rosen RF, Tomidokoro Y, Ghiso JA, Walker LC. SDS-PAGE/immunoblot detection of Aβ multimers in human cortical tissue homogenates using antigen-epitope retrieval. J Vis Exp 2010;1916.
  21. Mila-Aloma M, Suarez-Calvet M, Molinuevo JL. Latest advances in cerebrospinal fluid and blood biomarkers of Alzheimer's disease. Ther Adv Neurol Disorder 2019;12:1756286419888819.